# Protagonist Therapeutics, Inc (PTGX) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Protagonist Therapeutics, Inc's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/PTGX/mda/fy2025/): filed 2026-02-25; accession 0001104659-26-019696 (https://www.sec.gov/Archives/edgar/data/1377121/000110465926019696/ptgx-20251231x10k.htm); latest 10-K
- [FY 2024 MD&A](/company/PTGX/mda/fy2024/): filed 2025-02-21; accession 0001558370-25-001317 (https://www.sec.gov/Archives/edgar/data/1377121/000155837025001317/ptgx-20241231x10k.htm)
- [FY 2023 MD&A](/company/PTGX/mda/fy2023/): filed 2024-02-27; accession 0001558370-24-001850 (https://www.sec.gov/Archives/edgar/data/1377121/000155837024001850/ptgx-20231231x10k.htm)
- [FY 2022 MD&A](/company/PTGX/mda/fy2022/): filed 2023-03-15; accession 0001558370-23-003906 (https://www.sec.gov/Archives/edgar/data/1377121/000155837023003906/ptgx-20221231x10k.htm)
- [FY 2021 MD&A](/company/PTGX/mda/fy2021/): filed 2022-02-28; accession 0001558370-22-002385 (https://www.sec.gov/Archives/edgar/data/1377121/000155837022002385/ptgx-20211231x10k.htm)

Back to /company/PTGX/